Skip to main content

Table 2 Demographic and clinicopathological features of the study cohorts in Phase IV

From: Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA

Pathology

Plasma

PDAC

Healthy

Sample size

92

37

Age (years)

 Median

63.1

51.1

 Range

35–80

18–79

Sex: male/female

56/36

15/22

Stage

 I

25

-

 II

44

-

 III/IV

23

-

 N/A

0

-

Tumour size (cm)

 Median

3.0

-

 Range

1–8

-

CA19-9 (U/ml)

 Median

471.5

4.2

 Range

21.13–1200

1–9.57

 >37

15

0